MedPath
HSA Approval

DBL™ VINBLASTINE INJECTION

SIN07944P

DBL™ VINBLASTINE INJECTION

DBL™ VINBLASTINE INJECTION

December 9, 1994

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED
Licence HolderPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

L01CA01

vinblastine

Manufacturer Information

PFIZER PRIVATE LIMITED

HOSPIRA AUSTRALIA PTY LTD

Active Ingredients

VINBLASTINE SULPHATE

1 mg/ml

Vinblastine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.